Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy

Immune evasion is essential for carcinogenesis and cancer progression. Programmed death-ligand 1 (PD-L1), a critical immune checkpoint molecule, interacts with programmed death receptor-1 (PD-1) on immune cells to suppress anti-tumor immune responses. In the past decade, antibodies targeting PD-1/PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yao, Hong, Kai, Zhao, Yingchao, Xu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321661/
https://www.ncbi.nlm.nih.gov/pubmed/37415977
http://dx.doi.org/10.3389/fimmu.2023.1228200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321661/
https://www.ncbi.nlm.nih.gov/pubmed/37415977
http://dx.doi.org/10.3389/fimmu.2023.1228200

Ejemplares similares